Pancreatic Neoplasms: all 3,311 studies

Page 10 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.

• Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
• The Cancer of the Pancreas Screening-5 CAPS5)StudyRecruitingNCT02000089Phase 3
• Tissue Procurement and Natural History Study of Patients With Malignant MesotheliomaRecruitingNCT01950572
• Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of CancerRecruitingNCT01915225
• Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic CancerAvailableNCT01786850
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerRecruitingNCT01174121Phase 2
• Pancreatic Cancer GeneticsRecruitingNCT01102569
• PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic DiseaseRecruitingNCT01102556
• Pancreatic Adenocarcinoma Gene Environment Risk StudyRecruitingNCT00912717
• Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruitingNCT00899626
• Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruitingNCT00830557
• A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerTerminatedNCT06630325Phase 2Results posted
• Blue and Amber Light Exposure in Patients With Rectal and Pancreatic CancerTerminatedNCT06164691Not applicableResults posted
• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC PatientsCompletedNCT06119217Phase 2Results posted
• Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic AdenocarcinomaTerminatedNCT06069778Phase 1/2Results posted
• Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid TumorCompletedNCT06048367Phase 1Results posted
• A Supervised Prehabilitation Program for Patients With Pancreatic CancerActive, not recruitingNCT05692323Not applicableResults posted
• Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15CompletedNCT05546476Phase 2Results posted
• A Trial of NIS793 With FOLFIRINOX in Pancreatic CancerTerminatedNCT05546411Phase 2Results posted
• Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic AdenocarcinomaTerminatedNCT05525286Phase 1/2Results posted
• "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct CulturesTerminatedNCT05523154Not applicableResults posted
• Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or BladderCompletedNCT05512377Phase 2Results posted
• A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTerminatedNCT05451849Phase 1/2Results posted
• Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable DuodenoscopeCompletedNCT05429203Not applicableResults posted
• Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)CompletedNCT05259696Phase 1/2Results posted
• Role of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyTerminatedNCT05251233Phase 2Results posted
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsTerminatedNCT05194735Phase 1/2Results posted
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsTerminatedNCT05169437Phase 2Results posted
• Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
• A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTerminatedNCT05070247Phase 1/2Results posted
• Phase II Trial of Vemurafenib and Sorafenib in Pancreatic CancerCompletedNCT05068752Phase 2Results posted
• Cabozantinib and Pembrolizumab in Metastatic PancreasCompletedNCT05052723Phase 2Results posted
• Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic CancerCompletedNCT05014776Phase 2Results posted
• Milademetan in Advanced/Metastatic Solid TumorsTerminatedNCT05012397Phase 2Results posted
• Nutrition in Gastroenteropancreatic Neuroendocrine TumorCompletedNCT04986085Results posted
• Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsTerminatedNCT04985604Phase 2Results posted
• Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic CancerTerminatedNCT04975516Phase 2Results posted
• Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal PancreatectomyTerminatedNCT04965311Phase 2Results posted
• HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of GenomicsActive, not recruitingNCT04905082Not applicableResults posted
• Clinical Outcomes for Offering Genetic Testing in a Tiered ApproachCompletedNCT04902144Not applicableResults posted
• Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETsCompletedNCT04852679Phase 3Results posted
• Anamorelin Study for Advanced Pancreatic CancerTerminatedNCT04844970Phase 2Results posted
• XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic CancerCompletedNCT04825288Phase 1/2Results posted
• Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic CancerCompletedNCT04820179Phase 2Results posted
• Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic CancerTerminatedNCT04698915Phase 2Results posted
• Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract TumorsTerminatedNCT04683939Phase 1/2Results posted
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsTerminatedNCT04644315Phase 2Results posted
• Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid TumorsActive, not recruitingNCT04616534Phase 1Results posted
• Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) InhibitionCompletedNCT04542291Phase 1Results posted
• Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer PatientsTerminatedNCT04536077Phase 2Results posted
• Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic CancerCompletedNCT04524702Phase 2Results posted
• Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) PatientsCompletedNCT04524442Phase 4Results posted
• Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerActive, not recruitingNCT04514497Phase 1Results posted
• Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal CancerCompletedNCT04505553Phase 2Results posted
• A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)TerminatedNCT04504916Phase 2Results posted
• Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic CancerCompletedNCT04493060Phase 2Results posted
• RNA Precision Oncology in Advanced Pancreatic CancerTerminatedNCT04476537Not applicableResults posted
• Niraparib + Dostarlimab + RT in Pancreatic CancerCompletedNCT04409002Phase 2Results posted
• Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E MutationTerminatedNCT04390243Phase 2Results posted
• CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except MelanomaTerminatedNCT04387071Phase 1/2Results posted
• LY3214996 +/- HCQ in Pancreatic CancerCompletedNCT04386057Phase 2Results posted
• NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsCompletedNCT04332653Phase 1/2Results posted
• Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas CancerTerminatedNCT04327986Phase 1/2Results posted
• TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersCompletedNCT04306900Phase 1Results posted
• Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.CompletedNCT04299048Phase 1Results posted
• Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)Active, not recruitingNCT04281290Not applicableResults posted
• Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic CancerCompletedNCT04191421Phase 1/2Results posted
• Plerixafor and Cemiplimab in Metastatic Pancreatic CancerCompletedNCT04177810Phase 2Results posted
• FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic CancerTerminatedNCT04141995Phase 2Results posted
• A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal CancerCompletedNCT04137289Phase 1Results posted
• Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyCompletedNCT04068896Phase 1/2Results posted
• Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic CancerCompletedNCT03998566Not applicableResults posted
• Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCCompletedNCT03989115Phase 1/2Results posted
• Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant ChemotherapyTerminatedNCT03956056Phase 1Results posted
• A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)TerminatedNCT03948763Phase 1Results posted
• Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT03941093Phase 3Results posted
• TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic CancerCompletedNCT03914950Not applicableResults posted
• Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic CancerCompletedNCT03910387Phase 2Results posted
• TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced CancersCompletedNCT03884556Phase 1Results posted
• Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:CompletedNCT03861702Phase 2Results posted
• A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)TerminatedNCT03859869Phase 4Results posted
• Analyzing Childhood Recall Antigens in Patients With Pancreatic CancerTerminatedNCT03848182Phase 2Results posted
• SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive JaundiceTerminatedNCT03820544Not applicableResults posted
• Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal CancersCompletedNCT03801915Phase 2Results posted
• Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)CompletedNCT03797326Phase 2Results posted
• Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic CancersTerminatedNCT03785210Phase 2Results posted
• Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.CompletedNCT03767582Phase 1/2Results posted
• Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic SurgeryCompletedNCT03745794Phase 2Results posted
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 PatientsTerminatedNCT03745326Phase 1/2Results posted
• Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal AdenocarcinomaCompletedNCT03727880Phase 2Results posted
• Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic CancerTerminatedNCT03723915Phase 2Results posted
• Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or GemcitabineTerminatedNCT03714555Phase 2Results posted
• Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic CancerCompletedNCT03697564Phase 2Results posted
• PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminatedNCT03685591Phase 1Results posted
• First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid TumorsTerminatedNCT03681951Phase 2Results posted
• Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic CancerTerminatedNCT03649321Phase 1/2Results posted
• A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid TumorsTerminatedNCT03637491Phase 1/2Results posted
• Study of ADCT-301 in Patients With Selected Advanced Solid TumorsTerminatedNCT03621982Phase 1Results posted
• Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family MembersCompletedNCT03611309Not applicableResults posted
• EL CENTRO: Engaging Latinos in the Center of Cancer Treatment OptionsCompletedNCT03602885Not applicableResults posted

← Pancreatic Neoplasms overview